183 related articles for article (PubMed ID: 8030688)
1. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
[TBL] [Abstract][Full Text] [Related]
2. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
Samsioe G; Li C; Borgfeldt C; Wilawan K; Aberg A; Larsen S
Menopause; 2002; 9(5):335-42. PubMed ID: 12218722
[TBL] [Abstract][Full Text] [Related]
3. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
Davidson MH; Maki KC; Marx P; Maki AC; Cyrowski MS; Nanavati N; Arce JC
Arch Intern Med; 2000 Nov; 160(21):3315-25. PubMed ID: 11088095
[TBL] [Abstract][Full Text] [Related]
4. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
[TBL] [Abstract][Full Text] [Related]
5. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[TBL] [Abstract][Full Text] [Related]
6. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
Owens D; Collins PB; Johnson A; Tomkin GH
Diabet Med; 2000 Apr; 17(4):308-15. PubMed ID: 10821298
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.
Al-Azzawi F; Wahab M; Sami S; Proudler AJ; Thompson J; Stevenson J
Climacteric; 2004 Sep; 7(3):292-300. PubMed ID: 15669554
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
[TBL] [Abstract][Full Text] [Related]
9. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
Sendag F; Karadadas N; Ozsener S; Bilgin O
Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
[TBL] [Abstract][Full Text] [Related]
10. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
[TBL] [Abstract][Full Text] [Related]
11. Effect on lipoproteins of Trisequens, a combined hormone preparation.
Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
[TBL] [Abstract][Full Text] [Related]
12. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
[TBL] [Abstract][Full Text] [Related]
13. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
14. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
15. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.
Kotecha PT; Godsland IF; Crook D; Stevenson JC
Clin Endocrinol (Oxf); 2020 Apr; 92(4):303-311. PubMed ID: 31925799
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate.
Lindgren R; Berg G; Hammar M; Larsson-Cohn U; Olsson AG
Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):213-21. PubMed ID: 1294408
[TBL] [Abstract][Full Text] [Related]
17. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
Christiansen C; Riis BJ
Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
[TBL] [Abstract][Full Text] [Related]
19. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
[TBL] [Abstract][Full Text] [Related]
20. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
Nerbrand C; Nyberg P; Nordström L; Samsioe G
Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
